Advanced Biomed Inc Amortization of Intangible Assets
Advanced Biomed Inc (ADVB) reported Amortization of Intangible Assets of $30.19 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-05-15
- Advanced Biomed Inc amortization of intangible assets for the quarter ending 2025-03-31 was $30.19K, a 5.35% decline year-over-year.
- Advanced Biomed Inc amortization of intangible assets for the quarter ending 2024-12-31 was $33.55K, a 5.88% increase year-over-year.
- Advanced Biomed Inc amortization of intangible assets for the quarter ending 2024-03-31 was $31.90K.
- Advanced Biomed Inc amortization of intangible assets for the quarter ending 2023-12-31 was $31.69K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month |
|---|---|---|---|
| 2025-03-31 | $30.19K 10-Q · filed 2025-05-15 | $63.74K derived: sum of 2 quarters · filed 2025-05-15 | $98.67K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $33.55K 10-Q · filed 2025-04-15 | $68.48K 10-Q · filed 2025-04-15 | |
| 2024-03-31 | $31.90K 10-Q · filed 2025-05-15 | $63.59K derived: sum of 2 quarters · filed 2025-05-15 | $97.89K 10-Q · filed 2025-05-15 |
| 2023-12-31 | $31.69K 10-Q · filed 2025-04-15 | $65.99K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |